CMRL 1066 Medium (CIT Modification) from NUCLEUS BIOLOGICS
Search, find, compare suppliers for CMRL 1066 Medium (CIT Modification) products.
| Edit | |
|---|---|
| Product Name | CMRL 1066 Medium (CIT Modification) |
| Description | A line of cGMP, xeno-free media for culturing human pancreatic islets developed in collaboration with Dr. Elina Linetsky from the cGMP Advanced Cell and Biologic Products Manufacturing Facility, Diabetes Research Institute, University of Miami. The modified cGMP CMRL formulations was developed at University of Miami in preparation for clinical trials at the Clinical Islet Transplant Consortium (CIT). This CMRL 1066 medium formulation contains glutamine, insulin, transferrin. In support of transparency to streamline the development of novel cell therapies, all products are supplied with the ingredient list. |
| Size | 1L |
| Concentration | n/a |
| Applications | Cell culture |
| Other Names | Cell culture media |
| Gene, Accession, CAS # | n/a |
| Catalog # | 327 |
| Price | $246 |
| Order / More Info | CMRL 1066 Medium (CIT Modification) from NUCLEUS BIOLOGICS |
| Product Specific References | n/a |
NUCLEUS BIOLOGICS
NUCLEUS BIOLOGICS
10929 Technology Place
San Diego CA 92127
P: (858) 251-2010
info@nucleusbiologics.com
https://nucleusbiologics.com
Profile of NUCLEUS BIOLOGICS
Return to Products